You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia-Lymphoma, Adult T-Cell

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +23 more
  • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Determining the Mechanisms of Loss of CAR T Cell Persistence

Not yet recruiting
  • Acute Lymphoblastic Leukemia With Failed Remission
  • +4 more
    • (no location specified)
    Mar 29, 2023

    Non Hodgkin Lymphoma (NHL), Peripheral T-cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL) Trial in United States (KT-333)

    Recruiting
    • Non Hodgkin Lymphoma (NHL)
    • +4 more
    • Orange, California
    • +8 more
    Nov 29, 2022

    Non-hodgkin Lymphoma,B Cell, Multiple Myeloma, Acute Lymphoblastic Leukemia, Adult Trial in Atlanta (Fludarabine,

    Not yet recruiting
    • Non-hodgkin Lymphoma,B Cell
    • +2 more
    • Atlanta, Georgia
      Caitlin Guzowski
    Jun 9, 2023

    T-lymphoblastic Lymphoma, T-ALL Trial in Shanghai (CAR-T)

    Recruiting
    • T-lymphoblastic Lymphoma
    • T-ALL
    • CAR-T
    • Shanghai, China
      Shanghai Ruijin Hospital
    Nov 14, 2023

    B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

    Not yet recruiting
    • B Acute Lymphoblastic Leukemia
    • +2 more
    • Azacitidine Injection
    • +2 more
    • (no location specified)
    Oct 15, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia Trial (KUR-502)

    Not yet recruiting
    • NHL, Relapsed, Adult
    • +3 more
    • KUR-502
    • (no location specified)
    Aug 2, 2022

    Adult T-cell Leukemia/Lymphoma Trial in Japan (Valemetostat Tosylate)

    Active, not recruiting
    • Adult T-cell Leukemia/Lymphoma
    • Valemetostat Tosylate
    • Nagoya-shi, Aichi, Japan
    • +23 more
    Jan 11, 2022

    Leukemia, Lymphoblastic, Leukemia Trial in Houston (CB-103, Venetoclax)

    Not yet recruiting
    • Leukemia, Lymphoblastic
    • Leukemia
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 19, 2022

    B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Lymphoma Refractory, B-cell Lymphoma Recurrent Trial in Maywood (Fludarabine,

    Active, not recruiting
    • B-Cell Acute Lymphoblastic Leukemia, Adult
    • +2 more
    • Maywood, Illinois
      Loyola University
    Aug 11, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Chicago, Illinois
    • +2 more
    Jan 12, 2023

    CAR, Refractory Acute Lymphoblastic Leukemia, Relapsed Adult ALL Trial in Suzhou (Treatment)

    Recruiting
    • CAR
    • +2 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 27, 2022

    LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive

    Recruiting
    • LGLL - Large Granular Lymphocytic Leukemia
    • +13 more
    • Duarte, California
    • +9 more
    Aug 9, 2022

    Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Lymphoblastic Lymphoma
    • Frankfurt (Main), Germany
      University Hospital of Frankfurt (Main)
    Jul 1, 2022

    Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)

    Not yet recruiting
    • Acute Lymphoid Leukemia
    • Acute Lymphoblastic Leukemia
    • CD19 Directed CAR T Cell
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 12, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory Trial in Memphis (drug, device, biological)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • Acute Lymphoblastic Leukemia, Refractory
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jan 3, 2023

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory, Pediatric ALL Trial in Memphis (biological,

    Recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +2 more
    • CD19-CAR(Mem) T-cells
    • +5 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Aug 5, 2022

    Non-Hodgkin's Lymphoma (Disorder), Acute Lymphoid Leukemia, Disease (Disorder) Trial in Louisville, Houston (1A46 Injection)

    Recruiting
    • Non-Hodgkin's Lymphoma (Disorder)
    • Acute Lymphoid Leukemia, Disease (Disorder)
    • 1A46 Injection
    • Louisville, Kentucky
    • +1 more
    Aug 1, 2022

    Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

    Terminated
    Has Results
    • Acute Biphenotypic Leukemia
    • +29 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 4, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia

    Recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • CAR-20/19-T cells (1 x 10^5 CAR-20/19-T cells/kg)
    • +4 more
    • Milwaukee, Wisconsin
      Medical College of Wisconsin
    Sep 22, 2022

    Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

    Not yet recruiting
    • Pediatric Cancer
    • +11 more
    • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
    • Milwaukee, Wisconsin
      Children's Wisconsin
    Sep 14, 2022

    Leukemia Trial in Seattle (Patient-derived CD22-specific CAR T-cells also expressing an EGFRt)

    Active, not recruiting
    • Leukemia
    • Patient-derived CD22-specific CAR T-cells also expressing an EGFRt
    • Seattle, Washington
      Seattle Children's Hospital
    Feb 15, 2022

    Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

    Active, not recruiting
    • Adult Acute Lymphoblastic Leukemia in Remission
    • +14 more
    • radiation therapy
    • +8 more
    • Columbus, Ohio
      Arthur G. James Cancer Hospital and Solove Research Institute at
    Oct 7, 2022